FN1 and ovarian cancer: Moreover, it was shown that the knockdown of CD157 in human ovarian cancer cells changed their morphology and cytoskeleton organization, and attenuated the activation of intracellular signaling that impaired their binding to different matrix proteins, such as fibronectin, gelatin, collagen type I, laminin I, and others [3].